PI Pharma Insight

Lamzarin 30mg modified-release tablets

BNF presentation 0601021M0BQAAAM within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.

Product

Lamzarin

Chemical substance

Gliclazide

Presentation code

0601021M0BQAAAM

Usage overview

Total items and spend derived from NHS dispensing data.

Items dispensed

15

NHS spend (£)

£70.08

Recent activity

March 2025

Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.

Dispensing trend

Month-by-month national usage.

Month Items dispensed
March 2025 8
December 2024 3
November 2024 2
July 2024 1
November 2020 1

Top pharmacies dispensing this medicine

Identify providers with the highest utilisation to focus engagement and support.